ICH Control Group Guidance Fails To Harmonize Requirements - AstraZeneca
Executive Summary
The International Conference on Harmonization's clinical trial control groups guidance should offer more specific advice on how to select a control group acceptable to all ICH regulators, AstraZeneca said in recent comments to FDA.
You may also be interested in...
Past FDA Action Is Not Necessarily Predictive Of Future Behavior – Temple
Sponsors should not assume clinical trials are immune from evaluation according to updated efficacy standards, even if parameters are initially agreed upon with the agency
Past FDA Action Is Not Necessarily Predictive Of Future Behavior – Temple
Sponsors should not assume clinical trials are immune from evaluation according to updated efficacy standards, even if parameters are initially agreed upon with the agency
ICH Suggests Antihypertensive Drug Trials Add Focus On Systolic Measures
Clinical trials for new antihypertensive drugs need an increased focus on systolic blood pressure reduction, an International Conference on Harmonization draft guidance on antihypertensive drug development states.